Abbvie Inc. vs Medline Inc.
ABBV vs MDLN — side-by-side comparison from reported financials. ABBV leads 7, MDLN leads 3 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
| Metric | ABBV | MDLN |
|---|---|---|
| Price | $276.43 | $36.29 |
| Market cap | $488B | $31.8B |
| Revenue (TTM) | $64.4B | $29.9B |
| Revenue growth | +1.8% | +9.8% |
| Net margin | 9.8% | 1.7% |
| Free cash flow | $18.2B | $1.58B |
| Net cash (debt) | ($56.2B) | ($10.6B) |
| 1-year price return | +19.8% | — |
| P/E | 77.4 | 68.8 |
| P/E vs own history (cheap-side %) | 23% | 15% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 5% |
| Altman Z-score | 2.33 | 1.65 |
| CV checks passed | 9 of 11 | 5 of 11 |
| Employees | 57,000 | 45,000 |
Full résumé-style profiles: ABBV CV · MDLN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.